Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 402

    1.

    Cerebral angiitis in four patients with chronic GVHD.

    Sostak P, Padovan CS, Eigenbrod S, Roeber S, Segerer S, Schankin C, Siegert S, Saam T, Theil D, Kolb HJ, Kretzschmar H, Straube A.

    Bone Marrow Transplant. 2009 Nov 16. [Epub ahead of print]PMID: 19915632 [PubMed - as supplied by publisher]Related articles

    2.

    Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

    Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Socié G; ATG-Fresenius Trial Group.

    Lancet Oncol. 2009 Sep;10(9):855-64. Epub 2009 Aug 18.PMID: 19695955 [PubMed - indexed for MEDLINE]Related articles

    3.

    Large vessel vasculitis: manifestation of graft-versus-host disease?

    Sostak P, Saam T, Hacker M, Schankin Ch, Wagner J, Kolb HJ, Straube A.

    J Neurol. 2009 Nov;256(11):1947-9. Epub 2009 Aug 5.PMID: 19655192 [PubMed - in process]Related articles

    4.

    Stem cell transplants for patients with relapsed/refractory leukaemia.

    Kolb HJ, Simoes B, Schmid C.

    Curr Opin Hematol. 2009 Nov;16(6):444-52.PMID: 19652599 [PubMed - in process]Related articles

    5.
    6.

    Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.

    Kyriakou C, Canals C, Finke J, Kobbe G, Harousseau JL, Kolb HJ, Novitzky N, Goldstone AH, Sureda A, Schmitz N.

    J Clin Oncol. 2009 Aug 20;27(24):3951-8. Epub 2009 Jul 20.PMID: 19620487 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Steroid-refractory graft-versus-host disease : Extracorporeal irradiation of leucocytes induces immunotolerance.]

    Schinwald N, Rank A, Tischer J, Kolb HJ.

    Internist (Berl). 2009 Nov;50(11):1270-5. German. PMID: 19565209 [PubMed - in process]Related articles

    8.

    Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.

    Zorn J, Herber M, Schwamberger S, Panzer W, Adler H, Kolb HJ.

    Exp Hematol. 2009 Aug;37(8):998-1006. Epub 2009 May 13.PMID: 19446000 [PubMed - indexed for MEDLINE]Related articles

    9.

    The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.

    Bacher U, Klyuchnikov E, Zabelina T, Ottinger H, Beelen DW, Schrezenmeier H, Ehninger G, Müller C, Berger J, Suttorp M, Kolb HJ, Kröger N, Zander AR.

    Ann Hematol. 2009 Dec;88(12):1237-47. Epub 2009 Mar 25.PMID: 19319532 [PubMed - in process]Related articles

    10.

    Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.

    Rieger CT, Rieger H, Kolb HJ, Peterson L, Huppmann S, Fiegl M, Ostermann H.

    Transpl Infect Dis. 2009 Jun;11(3):220-6. Epub 2009 Mar 9.PMID: 19298239 [PubMed - indexed for MEDLINE]Related articles

    11.

    The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders.

    Scholl N, Loibl J, Kremser A, Liepert A, Grabrucker C, Salih HR, Kolb HJ, Schmetzer HM.

    Leuk Lymphoma. 2009 Mar;50(3):427-36.PMID: 19225975 [PubMed - indexed for MEDLINE]Related articles

    12.

    Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.

    Valent P, Hofmann WK, Büsche G, Sotlar K, Horny HP, Haase D, Haferlach T, Kern W, Bettelheim P, Baumgartner C, Sperr WR, Nösslinger T, Wimazal F, Giagounidis AA, Lübbert M, Krieger O, Kolb HJ, Stauder R, Pfeilstöcker M, Gattermann N, Fonatsch C, Aul C, Germing U.

    Ann Hematol. 2009 Jul;88(7):607-11. Epub 2009 Jan 16.PMID: 19148644 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.

    Schuster FR, Buhmann R, Reuther S, Hubner B, Grabrucker C, Liepert A, Reibke R, Lichtner P, Yang T, Kroell T, Kolb HJ, Borkhardt A, Schmetzer H.

    Cancer Genomics Proteomics. 2008 Sep-Oct;5(5):275-86.PMID: 19129558 [PubMed - indexed for MEDLINE]Related articles

    14.

    Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.

    Holler E, Kolb HJ, Greinix H, Perrotin D, Campilho F, Aversa F, Gil L, Cornelissen J, Varanese L, Schacht A, Friese A, Rustige J.

    Bone Marrow Transplant. 2009 Mar;43(6):491-7. Epub 2008 Dec 15.PMID: 19079317 [PubMed - indexed for MEDLINE]Related articles

    15.

    Graft-versus-leukemia effects of transplantation and donor lymphocytes.

    Kolb HJ.

    Blood. 2008 Dec 1;112(12):4371-83. Review.PMID: 19029455 [PubMed - indexed for MEDLINE]Related articles

    16.

    PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.

    Ghoreschi K, Thomas P, Penovici M, Ullmann J, Sander CA, Ledderose G, Plewig G, Kolb HJ, Röcken M.

    Eur J Dermatol. 2008 Nov-Dec;18(6):667-70. Epub 2008 Oct 27.PMID: 18955201 [PubMed - indexed for MEDLINE]Related articles

    17.

    Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.

    Buhmann R, Simoes B, Stanglmaier M, Yang T, Faltin M, Bund D, Lindhofer H, Kolb HJ.

    Bone Marrow Transplant. 2009 Mar;43(5):383-97. Epub 2008 Oct 13.PMID: 18850012 [PubMed - indexed for MEDLINE]Related articles

    18.

    Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.

    Gerbitz A, Hillemanns P, Schmid C, Wilke A, Jayaraman R, Kolb HJ, Eissner G, Holler E.

    Biol Blood Marrow Transplant. 2008 Oct;14(10):1180-9.PMID: 18804049 [PubMed - indexed for MEDLINE]Related articles

    19.

    Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.

    Schetelig J, Bornhäuser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H, Stelljes M, Hegenbart U, Schäfer-Eckart K, Füssel M, Wiedemann B, Thiede C, Kienast J, Baurmann H, Ganser A, Kolb HJ, Ehninger G.

    J Clin Oncol. 2008 Nov 10;26(32):5183-91. Epub 2008 Sep 2.PMID: 18768435 [PubMed - indexed for MEDLINE]Related articles

    20.

    A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.

    Rieger CT, Ostermann H, Kolb HJ, Fiegl M, Huppmann S, Morgenstern N, Tischer J.

    Ann Hematol. 2008 Nov;87(11):915-22. Epub 2008 Jul 19.PMID: 18641986 [PubMed - indexed for MEDLINE]Related articles

    21.

    Canine embryo-derived stem cells and models for human diseases.

    Schneider MR, Wolf E, Braun J, Kolb HJ, Adler H.

    Hum Mol Genet. 2008 Apr 15;17(R1):R42-7. Review.PMID: 18632696 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.

    Flowers ME, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, Bacigalupo A, Kolb HJ, Bouzas L, Michallet M, Prince HM, Knobler R, Parenti D, Gallo J, Greinix HT.

    Blood. 2008 Oct 1;112(7):2667-74. Epub 2008 Jul 11. Erratum in: Blood. 2009 Apr 30;113(18):4478. PMID: 18621929 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Canine stem cell factor augments expression of matrix metalloproteinase-9 by CD34 cells.

    Ostronoff LK, Kremmer E, Fermín ML, Fragío C, Mysliwietz J, Kolb HJ, Tejero C.

    Cytotherapy. 2008;10(2):193-202.PMID: 18368598 [PubMed - indexed for MEDLINE]Related articles

    24.

    High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

    Kyriakou C, Canals C, Goldstone A, Caballero D, Metzner B, Kobbe G, Kolb HJ, Kienast J, Reimer P, Finke J, Oberg G, Hunter A, Theorin N, Sureda A, Schmitz N; Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

    J Clin Oncol. 2008 Jan 10;26(2):218-24. Erratum in: J Clin Oncol. 2009 Jul 1;27(19):3262. PMID: 18182664 [PubMed - indexed for MEDLINE]Related articles

    25.

    High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.

    Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J, Ledderose G, Oruzio D, Hiddemann W, Kolb HJ.

    Bone Marrow Transplant. 2008 Apr;41(8):721-7. Epub 2008 Jan 7.PMID: 18176613 [PubMed - indexed for MEDLINE]Related articles

    26.

    Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement.

    Hauer J, Tosi S, Schuster FR, Harbott J, Kolb HJ, Borkhardt A.

    Pediatr Blood Cancer. 2008 Apr;50(4):921-3.PMID: 17960638 [PubMed - indexed for MEDLINE]Related articles

    27.

    Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.

    Schmid C, Labopin M, Nagler A, Bornhäuser M, Finke J, Fassas A, Volin L, Gürman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V; EBMT Acute Leukemia Working Party.

    J Clin Oncol. 2007 Nov 1;25(31):4938-45. Epub 2007 Oct 1.PMID: 17909197 [PubMed - indexed for MEDLINE]Related articles

    28.

    Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.

    Schuster IG, Busch DH, Eppinger E, Kremmer E, Milosevic S, Hennard C, Kuttler C, Ellwart JW, Frankenberger B, Nössner E, Salat C, Bogner C, Borkhardt A, Kolb HJ, Krackhardt AM.

    Blood. 2007 Oct 15;110(8):2931-9. Epub 2007 Jul 12.PMID: 17626842 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Canine embryo-derived stem cells--toward clinically relevant animal models for evaluating efficacy and safety of cell therapies.

    Schneider MR, Adler H, Braun J, Kienzle B, Wolf E, Kolb HJ.

    Stem Cells. 2007 Jul;25(7):1850-1. No abstract available. PMID: 17615273 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party.

    Knop S, Hebart H, Gratwohl A, Kliem C, Faul C, Holler E, Apperley J, Kolb HJ, Schaefer A, Niederwieser D, Einsele H.

    Leukemia. 2007 Aug;21(8):1830-3. Epub 2007 May 10. No abstract available. PMID: 17495972 [PubMed - indexed for MEDLINE]Related articles

    31.

    [Allogeneic stem cell transplantation in the management of acute myeloid leukemia]

    Schmid C, Kolb HJ.

    Med Klin (Munich). 2007 Apr 15;102(4):317-23. Review. German. PMID: 17426935 [PubMed - indexed for MEDLINE]Related articles

    32.

    Quantification of ex vivo generated dendritic cells (DC) and leukemia-derived DC contributes to estimate the quality of DC, to detect optimal DC-generating methods or to optimize DC-mediated T-cell-activation-procedures ex vivo or in vivo.

    Schmetzer HM, Kremser A, Loibl J, Kroell T, Kolb HJ.

    Leukemia. 2007 Jun;21(6):1338-41. Epub 2007 Mar 22. No abstract available. PMID: 17377593 [PubMed - indexed for MEDLINE]Related articles

    33.

    Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

    Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb HJ, Zander A, Zürbig P, Kellmann M, Ganser A.

    Blood. 2007 Jun 15;109(12):5511-9. Epub 2007 Mar 5.PMID: 17339419 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy.

    Weisser M, Schleuning M, Haferlach C, Schwerdtfeger R, Kolb HJ.

    Leuk Lymphoma. 2007 Feb;48(2):295-301.PMID: 17325889 [PubMed - indexed for MEDLINE]Related articles

    35.

    Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.

    Hehlmann R, Berger U, Pfirrmann M, Heimpel H, Hochhaus A, Hasford J, Kolb HJ, Lahaye T, Maywald O, Reiter A, Hossfeld DK, Huber C, Löffler H, Pralle H, Queisser W, Tobler A, Nerl C, Solenthaler M, Goebeler ME, Griesshammer M, Fischer T, Kremers S, Eimermacher H, Pfreundschuh M, Hirschmann WD, Lechner K, Wassmann B, Falge C, Kirchner HH, Gratwohl A.

    Blood. 2007 Jun 1;109(11):4686-92. Epub 2007 Feb 22.PMID: 17317858 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.

    Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA.

    Leuk Res. 2007 Jun;31(6):727-36. Epub 2007 Jan 25. Review.PMID: 17257673 [PubMed - indexed for MEDLINE]Related articles

    37.

    High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis.

    Steiner K, Graf M, Hecht K, Reif S, Rossbacher L, Pfister K, Kolb HJ, Schmetzer HM, Multhoff G.

    Leukemia. 2006 Nov;20(11):2076-9. Epub 2006 Sep 21. No abstract available. PMID: 16990768 [PubMed - indexed for MEDLINE]Related articles

    39.

    Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.

    Duell T, Poleck-Dehlin B, Schmid C, Wunderlich B, Ledderose G, Mittermuller J, Kolb HJ, Schmetzer H.

    Acta Haematol. 2006;116(2):131-6.PMID: 16914909 [PubMed - indexed for MEDLINE]Related articles

    40.

    Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.

    Hentschel N, Krusch M, Kiener PA, Kolb HJ, Salih HR, Schmetzer HM.

    Eur J Haematol. 2006 Aug;77(2):91-101. Epub 2006 Jun 23.PMID: 16800841 [PubMed - indexed for MEDLINE]Related articles

    41.

    The diallelic locus encoding the minor histocompatibility antigen HA-1 is evolutionarily conserved.

    Wieles B, Pool J, Wilke M, Weber M, Kolb HJ, Bontrop RE, Goulmy E.

    Tissue Antigens. 2006 Jul;68(1):62-5.PMID: 16774541 [PubMed - indexed for MEDLINE]Related articles

    42.

    Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.

    Pihusch V, Rank A, Steber R, Pihusch M, Pihusch R, Toth B, Hiller E, Kolb HJ.

    Transplantation. 2006 May 27;81(10):1405-9.PMID: 16732177 [PubMed - indexed for MEDLINE]Related articles

    43.

    A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.

    Weisser M, Tischer J, Schnittger S, Schoch C, Ledderose G, Kolb HJ.

    Haematologica. 2006 May;91(5):663-6. Epub 2006 Apr 19.PMID: 16627251 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.

    Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, Harsdorf SV, Scheid C, Holtick U, Greinix H, Keil F, Schneider B, Sandherr M, Bug G, Tischer J, Ledderose G, Hallek M, Hiddemann W, Kolb HJ.

    Blood. 2006 Aug 1;108(3):1092-9. Epub 2006 Mar 21.PMID: 16551971 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome.

    Rieger C, Rank A, Fiegl M, Tischer J, Schiel X, Ostermann H, Kolb HJ.

    Thromb Haemost. 2006 Jan;95(1):190-1. No abstract available. PMID: 16543979 [PubMed - indexed for MEDLINE]Related articles

    46.

    Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

    Gratwohl A, Brand R, Apperley J, Crawley C, Ruutu T, Corradini P, Carreras E, Devergie A, Guglielmi C, Kolb HJ, Niederwieser D; Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

    Haematologica. 2006 Apr;91(4):513-21. Epub 2006 Mar 1.PMID: 16533723 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.

    Maywald O, Pfirrmann M, Berger U, Breitscheidel L, Gratwohl A, Kolb HJ, Beelen DW, Tobler A, Metzgeroth G, Gnad SU, Hochhaus A, Hasford J, Hehlmann R, Reiter A; German CML Study Group; Swiss Group of Clinical Cancer Research.

    Leukemia. 2006 Mar;20(3):477-84.PMID: 16453005 [PubMed - indexed for MEDLINE]Related articles

    48.

    Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.

    Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb HJ, Holler E.

    Eur J Haematol. 2006 Feb;76(2):93-101.PMID: 16405429 [PubMed - indexed for MEDLINE]Related articles

    49.

    Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.

    Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Hiller E, Andreesen R, Kolb HJ, Holler E, Pihusch R.

    Transplantation. 2005 Nov 27;80(10):1376-82.PMID: 16340778 [PubMed - indexed for MEDLINE]Related articles

    50.

    Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.

    Boeck S, Hamann M, Pihusch V, Heller T, Diem H, Rolf B, Pihusch R, Kolb HJ, Pihusch M.

    Bone Marrow Transplant. 2006 Jan;37(1):57-64.PMID: 16258529 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...